Collagenase production by chondrocytes appears to play a major role in the development of osteoarthritis. Although the mechanisms regulating collagenase production by chondrocytes are not known, incubation of bovine chondrocytes in serum markedly decreases collagenase production. Since serum has been demonstrated to increase levels of phosphotyrosine (P-Tyr) in several cell types, we determined the effect of altering intracellular levels of P-Tyr on collagenase production. Both orthovanadate, a potent inhibitor of tyrosine phosphatases, and serum caused a marked increase in tyrosine phosphorylation. The increase in P-Tyr was associated with a decrease in the production of collagenase, suggesting that the two processes may be linked. Orthovanadate caused an increase in P-Tyr in the absence of serum, suggesting that P-Tyr levels in resting chondrocytes are regulated through activity of both tyrosine kinases and phosphatases. Orthovanadate and serum induced a synergistic increase in P-Tyr levels, suggesting that serum functions through increasing kinase activity rather than decreasing phosphatase activity. In the absence of serum, concentrations of orthovanadate which maximally inhibited collagenase production primarily increased phosphorylation of a 36 kDa protein, suggesting that the phosphorylation of this protein may play a major role in regulating collagenase production. Orthovanadate had limited effects on chondrocyte proteoglycan synthesis, morphology or viability in the presence or absence of serum, suggesting that the decrease in collagenase production was not due to non-specific inhibition of protein synthesis or cellular toxicity. Inhibition of tyrosine phosphatases by orthovanadate or activation of tyrosine kinases by addition of serum correlated with the inhibition of collagenase production.
INTRODUCTION
The cartilage matrix macromolecules consist mainly of proteoglycan, collagens and minor amounts of non-collagenous proteins (Howell, 1986) . In osteoarthritis these components undergo proteolytic degradation leading to cartilage erosion and loss ofjoint function (Howell, 1986) . Neutral metalloproteinases, including collagenase and proteoglycanase, are involved in the breakdown of these components in cartilage in the human disease and in experimental models of osteoarthritis (Ehrlich et al. 1978; Pelletier et al., 1983; Pettipher et al., 1986; Dingle et al., 1987; Dean et al., 1987; Duff, 1988) . Mammalian collagenase is capable of degrading native collagen (Murphy et al., 1988) and has been found to be elevated in osteoarthritic cartilage (Erlich et al., 1978) . The levels of collagenase parallel the severity of the disease until the late stages (Pelletier et al., 1983) . The loss of collagen and eventual cartilage erosion appear to be due to an increase in collagenase production by chondrocytes coupled with their inability to replace collagen lost from the matrix (Fell et al., 1976) . To date there is very little information on the mechanism regulating collagenase production by chondrocytes.
It has been shown that monolayer chondrocyte cultures produce collagenase constitutively in the absence of fetal bovine serum (FBS) (Ehrlich et al., 1977; Malemud et al., 1981; Cartwright et al., 1983) . Chondrocytes grown in the presence of FBS produce little or no collagenase constitutively (Kandel et al., 1987) . Recently, we have shown that FBS contains a factor which inhibits collagenase production (Kandel et al., 1990 ). Several growth factors, which are known to be present in FBS, have also been shown to modulate collagenase production in other cell types (Chua et al., 1985; Bauer et al., 1985; Edwards et al., 1987) . The observation that some of these growth factors stimulate tyrosine kinases (Edwards et al., 1985; Kohno, 1985) raised the possibility that tyrosine phosphorylation-dephosphorylation reactions may be involved in the regulation of collagenase production. In the present investigation we examined whether orthovanadate, a potent inhibitor of phosphotyrosine phosphatases (Swarup et al., 1982; Chasteen, 1983; Klarlund, 1985) , had an effect on collagenase production. Orthovanadate both increased phosphotyrosine (P-Tyr) levels and inhibited collagenase production by chondrocytes, suggesting that increases in P-Tyr may be involved in the regulation of collagenase production.
MATERIALS AND METHODS Materials
Goat anti-(type I collagen) antibodies were obtained from Southern Biotechnology Associates Inc., Birmingham, AL, U.S.A. Alkaline-phosphatase-conjugated rabbit anti-goat antibodies and the alkaline phosphatase kit used for determination of collagenase activity were purchased from Bio-Rad. Anti-PTyr monoclonal antibodies PY20 and PY69 were obtained from ICN. The alkaline phosphatase reaction kit used for Western blotting was purchased from Promega. Human recombinant interleukin 1/I was generously supplied by Ciba-Geigy, Basel, Switzerland. Phorbol 12-myristate 13-acetate, bacterial collagenase type II, Pronase type XIV from Streptomyces griseus, and low endotoxin BSA (fraction V) were purchased from Sigma. Highly purified BSA was purchased from Calbiochem.
Isolation of bovine articular chondrocytes
Bovine articular chondrocytes were isolated by the procedure previously described by Kuettner et al. (1982) The cells were incubated in I ml of medium containing the indicated concentrations of FBS and orthovanadate for 24 h at 37°C in a humidified atmosphere supplemented with 5 % CO2. The cell-conditioned medium was removed and assayed for collagenase activity.
Determination of collagenase activity
The cell-conditioned medium was removed from each well and assayed for collagenase activity by a modification of a procedure described previously (Kandel et al., 1990 
Measurement of tyrosine phosphorylation in chondrocytes
After incubation of cells, the cell-conditioned medium was removed and the cells were washed once with cold PBS. Cells were solubilized by the addition of 0.3 ml of Laemmli (1970) buffer containing 100 juM-orthovanadate and 5 % /,-mercaptoethanol. The extract was removed and boiled for 5 min. The samples were stored frozen at -70 'C. The proteins were separated on a 10 % polyacrylamide gel. After gel electrophoresis, the gel was incubated for 10 min in the transferring buffer. The proteins were transferred to nitrocellulose sheets by electrophoresing for 16 h at 200 mA. To ensure that all of the proteins were transferred, the gels were stained with Coomassie Blue following transfer. The nitrocellulose blots were blocked with 5 % BSA in PBS containing 0.02% NaN3 overnight at room temperature. The blots were incubated with 1 jug of anti-PTyr antibody in 1O ml of 1.5% BSA/PBS for 16 h at room temperature with constant shaking. The nitrocellulose sheet was washed twice with 150 ml of PBS for 10 min, then once with 1 % Nonidet P-40, and then twice with PBS. The anti-P-Tyr antibody bound to the proteins on the nitrocellulose was detected using one of two methods: alkaline phosphatase or 125I-labelled Protein A. For the alkaline phosphatase method, the washed nitrocellulose sheets were treated with 20 ml of alkaline-phosphataseconjugated sheep anti-mouse antibody (1: 3000) in 1.5 % BSA by incubating for 4 h at room temperature with constant shaking. The sheets were washed as described above and incubated with the colour reagent consisting of 20 ml of 20 mM-Tris/HCI, pH 9.5, 100 mM-NaCl, 5 mM-MgCl2, 132 jul of Nitro Blue Tetrazolium and 66 jul of 5-bromo-4-chloro-3-indolyl phosphate (BCIP) (Promega kit) until colour developed. The reaction was stopped by removing the substrate and adding 20 ml of 20 mmTris/HCl, pH 8.0, containing 5 mM-EDTA.
For detection of anti-phosphotyrosine antibody with labelled Protein A, the sheets were incubated with 1O ml of 1.5 % BSA in PBS containing 2 ,ug of rabbit anti-mouse IgG by incubating for 4 h at room temperature with shaking. The sheet was washed as described above and then treated with 1O ml of 1.5 The amount of keratan sulphate in the conditioned medium was determined using an inhibition e.l.i.s.a. method described previously (Cruz et al., 1989 increased further (100 uM-orthovanadate in 15 % FBS, Fig. 1 ). Therefore maximal inhibition of collagenase production was associated with relatively low accumulation of P-Tyr.
Effect of orthovanadate on proteoglycan synthesis
Since orthovanadate decreased the levels of collagenase production, we determined whether this represented a general decrease in protein biosynthesis by chondrocytes. The effect of orthovanadate on proteoglycan synthesis was examined by determining the amount of keratan sulphate in the conditioned medium. Chondrocytes were incubated for 24 h in Ham's medium alone or supplemented with 150% FBS in the presence and absence of 50 /tM-orthovanadate. detectable effects on chondrocyte morphology and viability. Fig.  2 shows the morphology of chondrocytes incubated for 24 h in the presence and absence of 100 ,aM-orthovanadate. Varying the concentration of FBS or orthovanadate also did not affect cell morphology (results not shown).
In order to examine cell viability following a 24 h incubation with orthovanadate, cells were loaded with carboxyfluorescein diacetate and then examined for fluorescence (results not shown). At 1 h after loading the cells, no differences were detected in the fluorescence of the cells incubated in the presence and absence of orthovanadate. These results indicate that concentrations of up to 100 /tM-orthovanadate had no affect on cell viability.
Chondrocyte proliferation was determined by measuring [3H]thymidine incorporation under the same culture conditions used to examine the production of collagenase (results not shown). Chondrocytes incorporated only negligible amounts of [3H] thymidine even in the presence of FBS, indicating that very little proliferation occurs under the conditions examined. Concentrations of orthovanadate of up to 100 4m had no significant effect on the amount of thymidine incorporated by chondrocytes.
DISCUSSION
Tyrosine phosphorylation, although a relatively rare event, appears to regulate both cell proliferation and differentiation (Chou et al., 1987; Glenny et al., 1988; Chen et al., 1988) . Several growth factor receptors contain an intrinsic tyrosine kinase domain (Hunter, 1984; Bishop, 1985; Hanks et al., 1988) , and others appear to be associated with tyrosine kinases (Chou et al., 1987; Deuel, 1987; Hanks et al., 1988) , implicating tyrosine phosphorylation in the regulation of cell proliferation. In addition, several of the proto-oncogenes encode for proteins with tyrosine kinase activity (Hunter, 1984; Bishop, 1985; Hanks et al., 1988) . However, brain, which contains few proliferating cells, is one of the richest sources of tyrosine kinase activity (Hanks et al., 1988) . Thus tyrosine phosphorylation probably plays a major role in the function of differentiated cells.
We have investigated the role of tyrosine phosphorylation in collagenase production by chondrocytes by altering the activity of tyrosine kinases using serum and decreasing the activity of tyrosine phosphatases using orthovanadate. In both cases, the increase in tyrosine phosphorylation was associated with a marked decrease in collagenase production. In contrast, production of proteoglycans was markedly increased with serum and slightly increased or not affected by orthovanadate in the absence or presence respectively of serum, indicating that the changes in collagenase production did not reflect a generalized inhibition of protein synthesis or secretion.
Orthovanadate in the presence of serum induced a synergistic increase in tyrosine phosphorylation, suggesting that the two agents are acting through different mechanisms. Serum stimulates tyrosine kinase activity (Edwards et al., 1985; Kohno, 1985) and orthovanadate is most probably inhibiting the activity of tyrosine phosphatases (Swarup et al., 1982; Chasteen, 1983; Nelson & Branton, 1984; Spigelman et al., 1987) . In the absence of serum, orthovanadate also increased the P-Tyr levels in several proteins. This was probably the consequence of inhibition of tyrosine phosphatases in the presence of constitutive tyrosine kinase activity; however, it is not possible to eliminate a direct effect of orthovanadate on tyrosine kinase activity. Similarly, although orthovanadate has been demonstrated to inhibit ion-pumping ATPases (Josephson & Cantley, 1977; Chasteen, 1983) and to activate guanine-nucleotide-binding proteins (Bigay et al., 1987) , these processes appear to require much higher concentrations of orthovanadate.
In the absence of serum, orthovanadate increased tyrosine phosphorylation predominantly of a 36 kDa protein (Fig. 1) . Although the level of tyrosine phosphorylation of a series of other proteins also increased, it is possible that the state of phosphorylation of the 36 kDa protein plays a role in the regulation of collagenase production. This is supported by the observation that the level of P-Tyr in the 36 kDa protein correlated closely with collagenase production, in that P-Tyr was markedly increased in the presence of orthovanadate alone and the levels of P-Tyr were not significantly further increased in the presence of concentrations of serum and orthovanadate above those which induced maximal inhibition of collagenase production.
In summary, increasing tyrosine phosphorylation by stimulating kinases with serum, by inhibiting phosphatases with orthovanadate or by a combination of the two correlated closely with a marked inhibition of collagenase production. Confirmation that the two processes are causally linked awaits identification of substrate(s) being phosphorylated and the regulatory mechanisms involved.
